331 related articles for article (PubMed ID: 4319494)
1. [Studies on the suitability of tissue culture neutralization tests in the government etesting of adsorbed foot-and mouth disease vaccines. 1. The content of neutralizing antibody in the serum of cattle after vaccination with adsorbed vaccine against type O2 virus in comparison with the direct immunity testing in cattle].
Rüting E; Seils H; Weyhe D; Benndorf E
Arch Exp Veterinarmed; 1969; 23(4):827-38. PubMed ID: 4319494
[No Abstract] [Full Text] [Related]
2. Foot-and-mouth disease vaccine: influence of the vaccine virus subtype on neutralizing antibody and resistance to disease.
Graves JH; McKercher PD; Callis JJ
Am J Vet Res; 1972 Apr; 33(4):765-8. PubMed ID: 4336082
[No Abstract] [Full Text] [Related]
3. [Humoral immune response in cattle vaccinated against aphthovirus. Study of the kinetics of protective and neutralizing antibodies].
Rojas GB; Rottenberg ME; Brunengo AM
Rev Argent Microbiol; 1984; 16(4):195-208. PubMed ID: 6101040
[TBL] [Abstract][Full Text] [Related]
4. [Studies of sero-neutralization in mice used for measurement of post-vaccination immunity of cattle to foot-and-mouth disease].
Maupas P; Perraud J
Bull Off Int Epizoot; 1969; 71(3-4):509-17. PubMed ID: 4323533
[No Abstract] [Full Text] [Related]
5. [Neutralizing and protecting antibodies in the serum cattle vaccinated against foot and mouth disease].
Brunengo AM; Díaz Primerano AM; Peso OA
Rev Asoc Argent Microbiol; 1977; 9(3):115-25. PubMed ID: 208108
[No Abstract] [Full Text] [Related]
6. Immunochemical studies of foot-and-mouh disease. IX. Differences in neutralizing activities of guinea pig and bovine 19S and 7S antibodies.
Wagner GG; Cown KM
J Immunol; 1971 Mar; 106(3):656-60. PubMed ID: 4323129
[No Abstract] [Full Text] [Related]
7. [Use of anti-foot-and-mouth disease vaccine in oil adjuvant in young cattle].
Brun A; Chappuis G; Favre H; Roulet C; Terré J
Dev Biol Stand; 1976; 35():117-22. PubMed ID: 198277
[TBL] [Abstract][Full Text] [Related]
8. Residual foot-and-mouth disease virus antibodies in French cattle and sheep six years after the vaccination ban.
Remond M; Kaiser C; Lebreton FO; Moutou F; Crucière C
Vet Res; 2001; 32(1):81-6. PubMed ID: 11254180
[TBL] [Abstract][Full Text] [Related]
9. [Measurement of immunity of cattle against foot-and-mouth disease with the use of the sheep test].
Fédida M; Dannacher G; Thomas JP; Peillon M; Coudert M
Bull Off Int Epizoot; 1970; 73(7):687-701. PubMed ID: 4323107
[No Abstract] [Full Text] [Related]
10. [Specific immunoprophylaxis trials with calves against foot-and-mouth disease].
Tekerlekov P; Uruchev K; Nikolova E; Genov I; Tsutsumanski V
Vet Med Nauki; 1980; 17(2):28-35. PubMed ID: 6254238
[TBL] [Abstract][Full Text] [Related]
11. Serological differentiation of foot-and-mouth disease virus strains in relation to selection of suitable vaccine viruses.
Rweyemamu MM; Pay TW; Parker MJ
Dev Biol Stand; 1976; 35():205-4. PubMed ID: 198288
[No Abstract] [Full Text] [Related]
12. [Post-vaccinal immunity against heterologous subtypes of the foot-and-mouth disease virus].
Sobko AI; Sokolov LN; Mishchenko VA; Maslova NS; Dudnikov AI
Veterinariia; 1977 Sep; (9):42-4. PubMed ID: 202059
[No Abstract] [Full Text] [Related]
13. [Detection of neutralizing antibodies in calves after single vaccination against foot-and-mouth disease virus type ASIA 1 in the field].
Dimitriadis I; Chondrokouki E
Berl Munch Tierarztl Wochenschr; 1991 Sep; 104(9):313-6. PubMed ID: 1659374
[TBL] [Abstract][Full Text] [Related]
14. [Immunologic relations between the foot-and-mouth disease virus isolates A5 Westerwald 1951 and A5 Bernbeuren 1984].
Bengelsdorff HJ
Berl Munch Tierarztl Wochenschr; 1987 Aug; 100(8):264-8. PubMed ID: 2820373
[No Abstract] [Full Text] [Related]
15. [Cultivation of foot-and-mouth disease virus type O in tissue cultures and utilization of its mutability for the production of new vaccine strains].
Mitev G; Tekerlekov P
Arch Exp Veterinarmed; 1966 Mar; 20(1):91-7. PubMed ID: 4293437
[No Abstract] [Full Text] [Related]
16. Antibody response in bovine pharyngeal fluid following foot-and-mouth disease vaccination and, or, exposure to live virus.
Francis MJ; Ouldridge EJ; Black L
Res Vet Sci; 1983 Sep; 35(2):206-10. PubMed ID: 6314460
[TBL] [Abstract][Full Text] [Related]
17. Escape mutants of foot-and-mouth disease virus selected by monoclonal antibodies directed to a trypsin-sensitive neutralization epitope.
Das BR; Pattnaik B; Venkataramanan R; Rai DV
Acta Virol; 1997 Jun; 41(3):131-8. PubMed ID: 9385400
[TBL] [Abstract][Full Text] [Related]
18. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease.
Dunn CS; Samuel AR; Pullen LA; Anderson J
Virology; 1998 Jul; 247(1):51-61. PubMed ID: 9683571
[TBL] [Abstract][Full Text] [Related]
19. [Characterization of the antibodies inhibiting complement fixation in the sera of cattle immunized with an anti-aphthous vaccine].
Hessami M; Roumiantzeff M; Salvatori J; Caillere F
Bull Off Int Epizoot; 1969; 71(3-4):443-62. PubMed ID: 4101093
[No Abstract] [Full Text] [Related]
20. Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection.
Wong HT; Cheng SC; Chan EW; Sheng ZT; Yan WY; Zheng ZX; Xie Y
Virology; 2000 Dec; 278(1):27-35. PubMed ID: 11112477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
